The aim of the present docking study was to explore the putative role of boronic moieties in
molecules interacting on the binding site of the SARS-CoV-2 main protease. The …

Background: Treatment of the COVID19 pandemic requires drug development. Boron-
containing compounds are attractive chemical agents, some of them act as proteases …

Identification of disulfiram and neratinib as putative covalent inhibitors of SARS-CoV-2 virus
main protease M pro by a combination of 'on-top docking'procedure, expert evaluation of …

A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …

The deadly disease-causing novel coronavirus has recently swept across the world and
endangered many human lives. Although, various research on therapeutic measures to …

The severe acute respiratory syndrome SARS‐CoV‐2 is the causative agent of COVID‐19.
Preventing binding of SARS‐CoV‐2 Spike glycoprotein to human ACE2 enzyme and …

The infection by the new coronavirus SARS-CoV-2 (called as COVID-19 disease) is a
worldwide emergency, however, there is no antiviral treatment or vaccine until now. The …

The new SARS-CoV-2 coronavirus is the causative agent of the COVID-19 pandemic
outbreak that affected more than 190 countries worldwide with more than 292,000 confirmed …

The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is not showing any sign of slowing down even after the …

Due to the length of time required to develop specific antiviral agents, the World Health
Organization adopted the strategy of repurposing existing medications to treat Coronavirus …